Lymph-Node-Targeted Immune Activation by Engineered Block Copolymer Amphiphiles-TLR7/8 Agonist Conjugates

Area of Science:

• Immunology
• Polymer Chemistry
• Drug Delivery

Background:

• Small molecule immunomodulators, like Toll-like receptor (TLR) agonists, stimulate innate immune cells for antiviral and antitumor effects.
• Systemic circulation of these small molecules leads to "wasted inflammation" and toxicity.
• Targeting drug action to lymphoid tissues is crucial for enhancing efficacy and minimizing side effects.

Purpose of the Study:

• To develop a synthetic strategy for confining small molecule immunomodulators to lymphoid tissues.
• To improve the pharmacokinetic profile of TLR7/8 agonists for enhanced lymphatic delivery.
• To create a drug delivery system that responds to the acidic endosomal environment.

Main Methods:

• Covalent conjugation of a small molecule TLR7/8 agonist to a micelle-forming amphiphilic block copolymer.
• Design of block copolymers utilizing π-π stacking for micelle stability.
• Engineering block copolymers for pH-responsive amphiphilic to hydrophilic transition.

Main Results:

• The conjugated TLR7/8 agonist exhibited an altered pharmacokinetic profile, achieving highly efficient lymphatic delivery.
• Thermodynamically stable micelles were formed via π-π stacking between aromatic moieties in the block copolymers.
• The engineered block copolymers demonstrated an irreversible transition from amphiphilic to hydrophilic in response to acidic endosomal pH.

Conclusions:

• Conjugation of small molecule immunomodulators to amphiphilic block copolymers is an effective strategy for targeted lymphatic delivery.
• The developed micelle system enhances drug efficacy by concentrating it in lymphoid tissues.
• The pH-responsive nature of the micelles offers potential for controlled drug release within endosomes, optimizing immunomodulatory responses.